Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Sequential Group, Dose Ranging Safety and Efficacy Study of FG 4592 in Non-dialysis Chronic Kidney Disease (CKD) Subjects With Anemia

NCT01599507 is registered in ClinicalTrials.gov with Kyntra Bio as lead sponsor.

NCT NCT01599507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Sequential Group, Dose Ranging Safety and Efficacy Study of FG 4592 in Non-dialysis Chronic Kidney Disease (CKD) Subjects With Anemia
Lead sponsor
Kyntra Bio
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
January 31, 2013
Enrollment
91 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

anemia in chronic kidney disease